D. Morris

发表

The application of discovery toxicology and pathology towards the design of safer pharmaceutical lead candidates

J. Kramer, J. Sagartz, D. Morris, 2007, Nature Reviews Drug Discovery.

Species Comparison of the Role of p38 MAP Kinase in the Female Reproductive System

D. Morris, Z. Radi, R. Marusak, 2009, Journal of toxicologic pathology.

Abnormal transcription factor induction through the surface immunoglobulin M receptor of B-1 lymphocytes

D. Morris, T. Rothstein, Dale L. Morris, 1993, The Journal of experimental medicine.

Decreased surface IgM receptor-mediated activation of phospholipase Cγ2 in B-1 lymphocytes

D. Morris, T. Rothstein, 1994 .

Decreased surface IgM receptor-mediated activation of phospholipase C gamma 2 in B-1 lymphocytes.

D. Morris, T. Rothstein, 1994, International immunology.

Analysis of rat cytochrome P450 isoenzyme expression using semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR).

D. Morris, J. Davila, 1996, Biochemical pharmacology.

Revolution through Genomics in Investigative and Discovery Toxicology

D. Morris, C. Alden, L. Kier, 1999, Toxicologic pathology.

EFFECTS OF 2,3,7,8-TETRACHLORODIBENZO-p-DIOXIN (TCDD) ON THE IN VITRO ANTIBODY RESPONSE: Differential effects on the B lymphocyte depending on the state of in vivo activation and the modulation by serum-derived growth factors

D. Morris, 1991 .

2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) elevates basal B-cell intracellular calcium concentration and suppresses surface Ig- but not CD40-induced antibody secretion.

D. Morris, J. Karras, C. M. Kramer, 1996, Toxicology and applied pharmacology.

The CD11b promoter directs high-level expression of reporter genes in macrophages in transgenic mice.

R. Perlmutter, D. Tenen, D. Morris, 1995, Blood.

2,3,7,8-tetrachlorodibenzo-p-dioxin-induced changes in immunocompetence: possible mechanisms.

D. Morris, M. Holsapple, S. Wood, 1991, Annual review of pharmacology and toxicology.

CHANGES IN IMMUNOCOMPETENCE : Mechanisms

D. Morris, M. Holsapple, S. Wood, 1991 .

TNF-α release from human peripheral blood mononuclear cells to predict the proinflammatory activity of cytokines and growth factors

D. Morris, Y. Oshiro, 1997 .

Mechanistic Investigations of Test Article–Induced Pancreatic Toxicity at the Endocrine–Exocrine Interface in the Rat

Steven A. Bailey, D. Morris, Dean M. Messing, 2014, Toxicologic pathology.

Chapter 17 – CD5+ B (B-1) Cells and Immunity

D. Morris, T. Rothstein, 1994 .

Immune responses in asbestos-exposed individuals.

D. Morris, S. Greenberg, E. Lawrence, 1985, Chest.

Antiinflammatory Drug-Related Nephrotoxicity Interspecies Differences in Renal Localization of Cyclooxygenase Isoforms: Implications in Nonsteroidal

D. Morris, C. Alden, C. Venturini, 2011 .

Stereoselective effect of morphine on antinociception and endogenous opioid peptide levels in plasma but not cerebrospinal fluid of dogs.

D. Morris, W. Dewey, M. Adams, 1991, Life sciences.

Direct effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on human tonsillar lymphocytes.

D. Morris, M. Holsapple, S. Wood, 1993, Toxicology.

Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on humoral immunity: I. Similarities to Staphylococcus aureus Cowan Strain I (SAC) in the in vitro T-dependent antibody response.

S. D. Jordan, D. Morris, M. Holsapple, 1991, Immunopharmacology.

Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on humoral immunity: II. B cell activation.

D. Morris, M. Holsapple, 1991, Immunopharmacology.

Oral Administration of Soluble Guanylate Cyclase Agonists to Rats Results in Osteoclastic Bone Resorption and Remodeling with New Bone Formation in the Appendicular and Axial Skeleton

D. Morris, J. Warneke, B. Homer, 2015, Toxicologic pathology.

Role of TGF-β in RA-induced cleft palate in CD-1 mice

D. Morris, S. Degitz, G. Foley, 1998 .

Immunosuppression in adult female B6C3F1 mice by chronic exposure to ethanol in a liquid diet.

S. D. Jordan, D. Morris, N. Kaminski, 1993, Immunopharmacology.

A review of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced changes in immunocompetence: 1991 update.

D. Morris, M. Holsapple, S. Wood, 1991, Toxicology.

Differential Display in Rat Livers Treated for 13 Weeks with Phenobarbital Implicates a Role for Metabolic and Oxidative Stress in Nongenotoxic Carcinogenicity

K. Kolaja, J. Kramer, D. Morris, 2005, Toxicologic pathology.

Growth‐promoting action of gastrin on human colonic and gastric tumour cells cultured in vitro

D. Morris, S. Watson, D. Morris, 1988, The British journal of surgery.

Cardiovascular action of hydroxyzine (atarax).

D. Morris, D. Hutcheon, A. Scriabine, 1956, The Journal of pharmacology and experimental therapeutics.

Direct effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on responses to lipopolysaccharide (LPS) by isolated murine B-cells.

D. Morris, J. Karras, M. Holsapple, 1993, Immunopharmacology.

Separation of Murine Splenic B- and T-Lymphocytes for Use in Immunotoxicological Studies

D. Morris, A. Munson, K. White, 1993 .

Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis

D. Morris, J. Hirsch, S. Ramaiah, 2010, Journal of Inflammation.

LHRH and LH in peripubertal female rats following prenatal and/or postnatal ethanol exposure.

D. Morris, H. Petersen, P. G. Harms, 1989, Life sciences.

Interspecies Differences in Renal Localization of Cyclooxygenase Isoforms: Implications in Nonsteroidal Antiinflammatory Drug-Related Nephrotoxicity

D. Morris, C. Alden, C. Venturini, 1998, Toxicologic pathology.

Phenobarbital Does Not Promote Hepatic Tumorigenesis in a Twenty-Six-Week Bioassay in p53 Heterozygous Mice

D. Morris, C. Alden, R. T. Bunch, 1998, Toxicologic pathology.

Immunophenotyping analysis of peripheral blood, splenic, and thymic lymphocytes in male and female rats.

D. Morris, W. Komocsar, 1997, Journal of pharmacological and toxicological methods.

Human xylazine overdose: a comparative review with clonidine, phenothiazines, and tricyclic antidepressants.

D. Morris, D. Spyker, J. Shipe, 1981, Clinical toxicology.

Characterization of the role played by antigen challenge in the suppression of in vivo humoral immunity by 2,3,7,8-tetrachlorodibenzo-p -dioxin (TCDD)

D. Morris, N. Kaminski, M. Holsapple, 1997, Archives of Toxicology.

Serum modulation of the effects of TCDD on the in vitro antibody response and on enzyme induction in primary hepatocytes.

D. Morris, J. Karras, Y. Chun, 1994, Immunopharmacology.

Enhanced suppression of humoral immunity in DBA/2 mice following subchronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).

D. Morris, M. Holsapple, N. Snyder, 1992, Toxicology and applied pharmacology.

Suckling inhibits release of luteinizing hormone-releasing hormone from the bovine median eminence following ovariectomy.

D. Morris, D. Forrest, D. Zalesky, 1990, Journal of animal science.

A priming effect of naloxone on in vitro LHRH release from the hypothalamus of mid-luteal ewes.

D. Morris, P. G. Harms, T. Wu, 1991, Biology of reproduction.

Acute Lymphoid and Gastrointestinal Toxicity Induced by Selective p38α Map Kinase and Map Kinase–Activated Protein Kinase-2 (MK2) Inhibitors in the Dog

David R. Anderson, J. Kramer, J. Sagartz, 2010, Toxicologic pathology.

Peptide-based in vitro assay for the detection of reactive metabolites.

D. Morris, D. Thompson, R. Mueller, 2008, Chemical research in toxicology.

Analysis of cytochrome P450 and phase II conjugating enzyme expression in adult male rat hepatocytes

D. Morris, J. Davila, Julio C. Davila, 1999, In Vitro Cellular & Developmental Biology - Animal.

Naltrexone therapy of apnea in children with elevated cerebrospinal fluid β‐endorphin

D. Morris, A. Zimmerman, W. Dewey, 1990 .

Increased cerebrospinal fluid beta-endorphin immunoreactivity in infants with apnea and in siblings of victims of sudden infant death syndrome.

D. Morris, W. Dewey, E. Myer, 1987, The Journal of pediatrics.

Analysis of B-1 Cell Activation

D. Morris, T. Rothstein, 1995 .

Cimetidine inhibits in vivo growth of human colon cancer and reverses histamine stimulated in vitro and in vivo growth.

D. Morris, D. Morris, J. Lawson, 1994, Gut.

Exploration of the Transformation Potential of a Unique Male Rat Protein Alpha2u-Globulin Using Hamster Embryonic Cells

D. Morris, C. Alden, T. Eurell, 1998, Toxicologic pathology.

Elucidation of cellular targets responsible for tetrachlorodibenzo-p-dioxin (TCDD)-induced suppression of antibody responses: I. The role of the B lymphocyte.

D. Morris, M. Holsapple, R K Dooley, 1988, Immunopharmacology.

Constitutive and inducible levels of egr-1 and c-myc early growth response gene expression in self-renewing B-1 lymphocytes.

D. Morris, T. Rothstein, Z. Wang, 1995, Cellular immunology.

The Pathologist and Toxicologist in Pharmaceutical Product Discovery

J. Sagartz, D. Morris, C. Alden, 1999, Toxicologic pathology.

Characterization of the effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin in B6C3F1 and DBA/2 mice following single and repeated exposures

S. D. Jordan, D. Morris, N. Kaminski, 1998, Archives of Toxicology.